Behind the work
Biotech
Biotech innovation demands precision, clarity, and credibility. We partner with research-driven teams and emerging life sciences companies to translate complex science into compelling digital platforms.

Communicating Complexity in Biotech
Biotech innovation moves fast—but communication often lags behind. From early discovery to clinical trials and commercialization, research teams and startups face the challenge of conveying highly technical work to non-technical audiences. Investors need clarity, partners need alignment, and regulators need precision. We help biotech organizations bridge these gaps by translating scientific complexity into clear, accessible, and purpose-driven communication.
Supporting the Full Development Lifecycle
Whether a company is working on gene therapies, novel biologics, diagnostics, or data-driven platforms, each stage of the biotech pipeline comes with its own communication challenges. Early-phase teams need to articulate their value proposition in the absence of complete data. Clinical-stage companies must balance hope with rigor. And late-stage firms preparing for market entry must navigate messaging for investors, providers, and patients simultaneously. Our role is to support communication across the lifecycle—adapting tone, format, and strategy as the science evolves.
Clarity Without Compromise
Scientific integrity is non-negotiable. But that doesn't mean communication has to be difficult or opaque. We specialize in working with technical content to ensure accuracy without sacrificing clarity. Whether it's creating mechanism-of-action visuals, investor decks, pipeline overviews, or regulatory submissions, we collaborate with scientific and medical teams to ensure every word and visual reflects the underlying data—while remaining digestible to the intended audience.
Audience-Specific Messaging
Biotech teams communicate with a wide range of stakeholders, each with different priorities and levels of technical fluency. We help tailor messaging for:
Investors, who need clear risk-reward framing and product-market fit
Regulators, who require precision and consistency
Scientific advisors, who care about methodology and robustness
Patients and advocacy groups, who need empathy, transparency, and hope
Partners and collaborators, who look for alignment, credibility, and vision
By segmenting audiences and creating purpose-built content, we help biotech companies meet each stakeholder where they are.
Design as a Tool for Understanding
In biotech, visual communication is often as important as verbal communication. Molecular pathways, platform technologies, clinical data—these demand design that is not only beautiful but also functionally precise. We use information design to make data more intuitive, processes more legible, and technologies more memorable. From slide decks and posters to websites and interactive explainers, our visual work is driven by the same attention to detail as the science itself.
Scaling Communication Alongside Science
As biotech companies grow, so do their communication needs. What worked in a Series A pitch deck won't suffice for a Phase III trial update. We help teams develop scalable systems for messaging, documentation, and stakeholder engagement. This includes brand positioning, messaging architecture, internal alignment tools, and external assets that evolve with the science. Our aim is to ensure that communication never becomes a bottleneck to scientific or commercial progress.
Interdisciplinary Collaboration
We bring a hybrid skillset that blends science communication, design thinking, regulatory fluency, and strategic messaging. Our team includes individuals with backgrounds in molecular biology, public health, medical writing, and creative direction—allowing us to work fluidly across disciplines. This enables us to quickly understand technical content, engage effectively with subject-matter experts, and co-create communication tools that are both credible and compelling.
Putting Innovation Into Context
In a crowded and fast-moving landscape, biotech companies must not only explain what they do, but why it matters. We help teams contextualize their science in terms of unmet need, patient impact, and long-term value—ensuring their innovation is not only seen, but understood. Whether the audience is a scientific conference, a government grant panel, or a potential partner across the table, our job is to make sure the science speaks for itself—clearly, confidently, and with purpose.
